Effect of liraglutide and metformin on constitution, metabolism and micro-inflammatory state in newly diagnosed type 2 diabetic mellitus patients with obesity

Effect of liraglutide and metformin on constitution, metabolism and micro-inflammatory state in newly diagnosed type 2 diabetic mellitus patients with obesity

Objective: To analyze the effect of liraglutide and metformin on the constitution, metabolism and micro-inflammatory state in newly diagnosed type 2 diabetic mellitus patients with obesity. Methods: A total of 55 cases of newly diagnosed type 2 diabetic mellitus patients with obesity were include...

Full description

Bibliographic Details
Main Authors:	Xiu-Ping Han, Tao Sun, Li-Li Wang, Yu-Mei He, Mei Zhang, Zhuan-Xia Li, Lin-Juan Li, Yong-Li Zhang
Format:	Article
Language:	English
Published:	Editorial Board of Journal of Hainan Medical University 2016-08-01
Series:	Journal of Hainan Medical University
Subjects:	Type 2 diabetic mellitus with obesity Liraglutide Metformin Micro-inflammation
Online Access:	http://www.hnykdxxb.com/PDF/201616/10.pdf

Similar Items

Effects of liraglutide combined with metformin on lipid metabolism and micro-inflammatory response in T2DM patients with obesity
by: Wei-Huan Zhang, et al.
Published: (2018-08-01)

Liraglutide suppresses non-esterified free fatty acids and soluble vascular cell adhesion molecule-1 compared with metformin in patients with recent-onset type 2 diabetes
by: Xiao-min Chen, et al.
Published: (2018-04-01)

Liraglutide and Metformin alone or combined therapy for type 2 diabetes patients complicated with coronary artery disease
by: Ying Liu, et al.
Published: (2017-12-01)

Regulating effect of liraglutide therapy on metabolic disorders in patients with newly diagnosed type 2 diabetes complicated with obesity
by: Dong-Mei Gao, et al.
Published: (2017-08-01)

Liraglutide overdose: A case report and an updated review
by: Sharafaldeen Bin Nafisah, et al.
Published: (2020-01-01)

Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes
by: Vaia Lambadiari, et al.
Published: (2018-01-01)

Efficacy and safety of liraglutide in Indian adolescents with obesity
by: I. S. Kochar, et al.
Published: (2019-06-01)

Effects of lilalutine on blood glucose, lipid, blood pressure and carotid plaque in patients with type 2 diabetes mellitus complicated with atherosclerosis
by: Ya Chen, et al.
Published: (2019-05-01)

Experience of the use of liraglutide (Victoza) in women with type 2 diabetes mellitus and obesity
by: Vladimir Ivanovich Kudinov, et al.
Published: (2011-06-01)

Liraglutide exhibits anti-inflammatory activity through the activation of the PKA/CREB pathway
by: Li Wang, et al.
Published: (2019-10-01)

Clinical Impact of Liraglutide as a Treatment of Obesity
by: Alruwaili H, et al.
Published: (2021-03-01)

Efficacy of Liraglutide Application in Patients with Diabetes Mellitus Type 2 and Obesity in Real Clinical Practice (Literature Review the and Findings of Our Own Observations)
by: V.I. Pankiv
Published: (2014-09-01)

Liraglutide ameliorates beta-cell function, alleviates oxidative stress and inhibits low grade inflammation in young patients with new-onset type 2 diabetes
by: Wen-qiang Zhang, et al.
Published: (2018-12-01)

Liraglutide Improves Non-Alcoholic Fatty Liver Disease In Diabetic Mice By Modulating Inflammatory Signaling Pathways
by: Luo Y, et al.
Published: (2019-12-01)

Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity
by: Li Chun-jun, et al.
Published: (2012-11-01)

Effects of liraglutide on obesity-associated functional hypogonadism in men
by: M Jensterle, et al.
Published: (2019-02-01)

Effect of liraglutide combined with basal insulin on blood glucose control, lipid metabolism and oxidative stress in patients with newly diagnosed type 2 diabetes mellitus complicated by obesity
by: Fei-Fei He, et al.
Published: (2018-02-01)

Liraglutide attenuates atherosclerosis via inhibiting ER-induced macrophage derived microvesicles production in T2DM rats
by: Jinjin Li, et al.
Published: (2017-12-01)

Effects of liraglutide on lipolysis and the AC3/PKA/HSL pathway
by: Li Z, et al.
Published: (2019-09-01)

Case Report: Liraglutide for Weight Management in Beckwith-Wiedemann Syndromic Obesity
by: Marina Caputo, et al.
Published: (2021-06-01)

Prediction of early response to liraglutide therapy in patients with obesity
by: Oksana V. Logvinova, et al.
Published: (2020-06-01)

Feasibility, Adherence and Efficacy of Liraglutide Treatment in a Sample of Individuals With Mood Disorders and Obesity
by: Alessandro Cuomo, et al.
Published: (2019-01-01)

LIRAGLUTIDE: SUCESSO NO TRATAMENTO DO DIABETES MELLITUS EM MONOTERAPIA E ASSOCIAÇÕES – REVISÃO SISTEMÁTICA
by: George Robson Ibiapina, et al.
Published: (2011-12-01)

Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction
by: Qi Q, et al.
Published: (2017-07-01)

Liraglutide: A review of its therapeutic use as a once daily GLP-1 analog for the management of type 2 diabetes mellitus
by: Mala Dharmalingam, et al.
Published: (2011-01-01)

Liraglutide Ameliorates Erectile Dysfunction via Regulating Oxidative Stress, the RhoA/ROCK Pathway and Autophagy in Diabetes Mellitus
by: Penghui Yuan, et al.
Published: (2020-08-01)

A Randomized Phase 1 Pharmacokinetic Study Comparing the Potential Biosimilar LRG201902 With Liraglutide (Victoza®) in Healthy Male Subjects
by: Gang Mai, et al.
Published: (2021-01-01)

Successful rapid weight reduction and the use of liraglutide for morbid obesity in adolescent Prader-Willi syndrome
by: Yoo-Mi Kim, et al.
Published: (2020-03-01)

A Disease-Modifying Approach for Advanced Hidradenitis Suppurativa (Regimen with Metformin, Liraglutide, Dapsone, and Finasteride): A Case Report
by: Birgit N. Khandalavala
Published: (2017-07-01)

Liraglutide-induced injection site reaction
by: Nada Fouda Neel, et al.
Published: (2019-01-01)

Role of liraglutide in Alzheimer’s disease pathology
by: Maria Vargas-Soria, et al.
Published: (2021-06-01)

Liraglutide exerts an anti-inflammatory action in obese patients with type 2 diabetes
by: Savchenko Liudmyla G., et al.
Published: (2019-09-01)

A glucagon-like peptide-1 analog, liraglutide, ameliorates endothelial dysfunction through miRNAs to inhibit apoptosis in rats
by: Qian Zhang, et al.
Published: (2019-03-01)

The cumulative dose-dependent effects of metformin on the development of tuberculosis in patients newly diagnosed with type 2 diabetes mellitus
by: Eunyoung Heo, et al.
Published: (2021-09-01)

Adropin – Potential Link in Cardiovascular Protection for Obese Male Type 2 Diabetes Mellitus Patients Treated with Liraglutide
by: Tina Tičinović Kurir, et al.
Published: (2020-01-01)

Gglucagon-like peptide-1 analogue liraglutide (Saxenda®): mechanism of action, efficacy for the treatment of obesity
by: Tatiana I. Romantsova
Published: (2018-04-01)

Long-term efficacy of liraglutide in Indian patients with Type 2 diabetes in a real-world setting
by: Parjeet Kaur, et al.
Published: (2016-01-01)

Weight loss and persistence with liraglutide 3.0 mg by obesity class in the real‐world effectiveness study in Canada
by: Sean Wharton, et al.
Published: (2020-08-01)

Continuation of Liraglutide during Fasting is not Associated with Hypoglycaemia
by: Rosalie Koot, et al.
Published: (2017-10-01)

GLP-1 Analogue Liraglutide Attenuates Mutant Huntingtin-Induced Neurotoxicity by Restoration of Neuronal Insulin Signaling
by: Ching-Chi Chang, et al.
Published: (2018-08-01)